Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
8.16M | 9.26M | 8.93M | 18.62M | 14.36M | 10.77M | Gross Profit |
-2.94M | -2.81M | -949.00K | 1.67M | 2.18M | 1.03M | EBIT |
-10.51M | -10.35M | -6.04M | -1.77M | 1.52M | 648.95K | EBITDA |
-9.88M | -10.81M | -5.74M | -1.36M | 1.71M | 678.63K | Net Income Common Stockholders |
-13.37M | -13.65M | -7.34M | -2.46M | 1.14M | 464.98K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
17.65K | 420.13K | 221.76K | 810.37K | 1.31M | 489.85K | Total Assets |
9.83M | 11.31M | 14.20M | 20.85M | 11.80M | 11.27M | Total Debt |
4.39M | 4.71M | 8.06M | 6.25M | 136.48K | 88.50K | Net Debt |
4.38M | 4.29M | 7.84M | 5.44M | -1.18M | -401.35K | Total Liabilities |
25.24M | 25.65M | 20.92M | 20.23M | 10.03M | 10.72M | Stockholders Equity |
-15.41M | -14.34M | -6.72M | 617.45K | 1.77M | 555.69K |
Cash Flow | Free Cash Flow | ||||
-5.76M | -5.93M | -1.68M | -2.51M | 2.05M | 395.29K | Operating Cash Flow |
-5.76M | -5.93M | -1.68M | -2.45M | 2.07M | 466.21K | Investing Cash Flow |
744.78K | -40.00K | -437.09K | -269.77K | -1.19M | -216.93K | Financing Cash Flow |
5.77M | 6.17M | 1.53M | 2.22M | 41.85K | 100.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $36.70M | 1.84 | 26.72% | ― | -8.81% | ― | |
64 Neutral | $12.77B | 9.78 | 7.84% | 78.83% | 12.06% | -7.99% | |
60 Neutral | $19.34M | ― | -0.26% | ― | 48.84% | 98.75% | |
44 Neutral | $16.90M | ― | -90.36% | ― | -87.59% | 51.14% | |
39 Underperform | $548.99K | 0.03 | 108.03% | ― | ― | ― | |
35 Underperform | $20.72M | ― | 220.90% | ― | -92.71% | 39.07% | |
$6.05M | 244.68 | 0.14% | 7.83% | ― | ― |
On May 6, 2025, Nature’s Miracle Holding Inc. entered into an Equity Financing Agreement with GHS Investments, LLC, allowing for an equity line of credit up to $20 million over 24 months. This agreement, along with a Securities Purchase Agreement for Series A Preferred Stock, aims to bolster the company’s financial position and support its growth in the agriculture technology sector. The financing arrangement includes the issuance of common and preferred shares, with specific terms to manage ownership limits and conversion rights, potentially impacting the company’s market operations and stakeholder interests.